We used the data from 10 randomly chosen patients from our cohort of FMT patients and the same for 10 randomly chosen
patients who had received GFRT. We measured their microbiomes using 16S mRNA tests, the results are shown in Tables 3 and 4. The reference values for the laboratory were used for these tests are obtained from a specially selected verified subset of user’s data containing hundreds of samples which were identified as coming from healthy donors. The 16S mRNA test done on each patient before and after treatment showed no significant difference between the FMT and the GFRT groups. CLICK TO REVIEW